Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6S Trial: HES 130/0.4 vs Ringer's Acetate in Severe Sepsis
NCT00962156Phase 3Completed
- Sponsor
- Anders Perner
- Start
- Dec 2009
- Primary completion
- Mar 2012
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of hetastarch in sepsis, septic shock, sponsored by Anders Perner. Started Dec 2009; status: completed.
02
Drugs
hetastarch
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT00962156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00962156.